Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries

Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients’ and parents’ quality of life: the phenylketonuria – quality of life (PKU-QOL) questionnaires

(2015) Antoine Regnault et al.   Orphanet Journal of Rare Diseases

Longitudinal quality of life analysis in a phenylketonuria cohort provided sapropterin dihydrochloride

(2013) Teresa D Douglas et al.   Health and Quality of Life Outcomes

Quality of life among parents of children with phenylketonuria (PKU)

(2013) Astrid Fidika et al.   Health and Quality of Life Outcomes

Health-related quality of life in children and adolescents with phenylketonuria: unimpaired HRQoL in patients but feared school failure in parents

(2013) Eva Thimm et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study

(2013) Serwet Demirdas et al.   MOLECULAR GENETICS AND METABOLISM

Tetrahydrobiopterin (BH4) in PKU: effect on dietary treatment, metabolic control, and quality of life

(2012) B. Ziesch et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Adherence to diet and quality of life in patients with phenylketonuria

(2011) G Cotugno et al.   ACTA PAEDIATRICA

Impact of Patient-Reported Outcomes in Oncology: A Longitudinal Analysis of Patient-Physician Communication

(2011) Elena E. Takeuchi et al.   JOURNAL OF CLINICAL ONCOLOGY

Up to date knowledge on different treatment strategies for phenylketonuria

(2011) Amaya Bélanger-Quintana et al.   MOLECULAR GENETICS AND METABOLISM

Reporting health-related quality of life scores to physicians during routine follow-up visits of pediatric oncology patients: Is it effective?

(2011) Vivian Engelen et al.   PEDIATRIC BLOOD & CANCER

High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial

(2010) Amber E. ten Hoedt et al.   JOURNAL OF INHERITED METABOLIC DISEASE

The reality of dietary compliance in the management of phenylketonuria

(2010) Anita MacDonald et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Nutritional issues in treating phenylketonuria

(2010) François Feillet et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Phenylketonuria

(2010) Nenad Blau et al.   LANCET

Psychosocial aspects of PKU: Hidden disabilities – A review☆

(2009) J.K. Gentile et al.   MOLECULAR GENETICS AND METABOLISM

Monitoring and Discussing Health-Related Quality of Life in Adolescents With Type 1 Diabetes Improve Psychosocial Well-Being: A randomized controlled trial

(2008) M. de Wit et al.   DIABETES CARE

Evaluation of quality of life and description of the sociodemographic state in adolescent and young adult patients with phenylketonuria (PKU)

(2008) Eva Simon et al.   Health and Quality of Life Outcomes

Stability of blood phenylalanine levels and IQ in children with phenylketonuria

(2008) Vera Anastasoaie et al.   MOLECULAR GENETICS AND METABOLISM

Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: A meta-analysis

(2008) Julia Albrecht et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS